Headaches and Hormones

Seminars in Pediatric Neurology

Volumn 17, Issue 2, 2010, Pages 100-104

  Pakalnis, Ann ^a   Gladstein, Jack ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DIHYDROERGOTAMINE; ETHINYLESTRADIOL; FOLLITROPIN; FROVATRIPTAN; GESTAGEN; GONADORELIN; HORMONE; LUTEINIZING HORMONE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PLACEBO; SEX HORMONE; SUMATRIPTAN; ZOLMITRIPTAN;

CEREBROSPINAL FLUID; CLINICAL TRIAL; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; EXERCISE; FEEDBACK SYSTEM; HEADACHE; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; INTRACRANIAL PRESSURE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MENSTRUAL MIGRAINE; OBESITY; ONSET AGE; PSEUDOTUMOR; PUBERTY; REVIEW; SEX DIFFERENCE;

ADOLESCENT; CHILD; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HEADACHE; HORMONES; HUMANS; MALE; MIGRAINE DISORDERS; OBESITY;

EID: 77953671229     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2010.04.007     Document Type: Review

References (51)

1. Gunner K.B., Smith H.D. Practice guideline and management of migraine headaches in children and adolescents. J Pediatr Health Care 2007, 21:327-332.
2. Bigal M., Liberman J.N., Lipton R.B. Age-dependent prevalence and clinical features of migraine. Neurology 2006, 67:246-251.
3. Lipton R.B., Stewart W.F., Diamond S., et al. Prevalence and burden of migraine in the United States: Data from the American Headache Study II. Headache 2001, 41:646-657.
4. Le Kesche L., Manal L.A., Grangoholt M.T., et al. Relationship of pain and symptoms to pubertal development in adolescents. Pain 2005, 118:201-209.
5. Kröner-Herwig B., Vath N. Menarche in girls and headache-A longitudinal analysis. Headache 2009, 49:860-867.
6. Slater S., Crawford M.J., Kubbouche M.A., et al. Effects of gender and age on pediatric headache. Cephalalgia 2009, 29:969-973.
7. Abu-Arafeh I., Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 1995, 309:765-769.
8. Martin V.T., Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis-Part 1. Headache 2006, 46:3-23.
9. Martin V.T., Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis-Part 2. Headache 2006, 46:365-386.
10. Finkelstein J.W. Endocrine Physiology at Puberty in Comprehensive Adolescent Health Care 1998, Mosby Year Book, St. Louis, MO.
11. Lay C.L., Broner S.W. Migraine in women. Neurol Clin 2009, 27:503-511.
12. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
13. Li C., Ford E.S., McGuire L.C., et al. Increasing trends in waist circumference and abdominal obesity among U.S. adults. Obesity 2007, 15:216-224.
14. Bigal M.E., Lipton R.B. Obesity is a risk factor for transformed migraine but not chronic tension type headache. Neurology 2006, 67:252-257.
15. Bigal M.E., Liberman J.N., Lipton R.B. Obesity and migraine: A population study. Neurology 2006, 66:545-550.
16. Horev A., Wirguin I., Lantsberg L., et al. A high incidence of migraine with aura among morbidly obese women. Headache 2005, 45:936-938.
17. Hershey A.D., Powers S.W., Nelson T.D., et al. Obesity in the pediatric headache population: A multicenter study. Headache 2009, 49:170-177.
18. Bigal M.E., Lipton R.B., Holladn P.R., et al. Obesity, migraine and chronic migraine, possible mechanisms of interaction. Neurology 2007, 68:1851-1861.
19. International Headache Society: The International Classification of Headache Disorders (ed 2). Cephalalgia 2004, 24(suppl 1):1-151.
20. Martin V.T., Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis. Part 1. Headache 2006, 46:3-23.
21. Crawford M.J., Lehman L., Slater S., et al. Menstrual migraine in adolescents. Headache 2009, 49:341-347.
22. Al-Walli N.S. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefaminic acid: Double blind study with placebo. Eur J Med Res 2000, 5:176-182.
23. Newman L.C., Lipton R.B., Lay C.L., et al. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998, 51:307-309.
24. Newman L.C., Mannix L.K., Landy S., et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: A randomized double-blind, placebo-controlled study. Headache 2001, 41:248-256.
25. Silberstein S.D., Elkin A.H., Schreiber C., et al. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004, 63:261-269.
26. Tuchman M.M., Hee A., Emeribe U., et al. Oral zolmitriptan in the short-term prevention of menstrual migraine: A randomized, placebo-controlled study. CNS Drugs 2008, 22:877-886.
27. Silberstein S.D., Bradley K. DHE-forty-five in the prophylaxis of menstrually related migraine. Cephalalgia 1996, 16:371.
28. Sulak P.J., Cressman B.E., Waldrop E., et al. Extending the duration of active oral contraceptive pills to mange hormone withdrawal symptoms. Obstet Gynecol 1997, 89:179-183.
29. Lay C.L., Broner S.W. Migraine in women. Neurol Clin 2009, 27:503-511.
30. Burkman R.T., Collins J.A., Shulman L.P., et al. Current perspectives on oral contraceptive use. Am J Obstet Gynecol 2001, 185:504-512.
31. International Headache Society: International Classification of Headache Disorders (ed 2). Cephalalgia 2004, 24(suppl 1):9-160.
32. Sulak P., Willis S., Kuehl T., et al. Headaches and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache 2007, 47:27-37.
33. Calhoun A., Ford S. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache 2008, 48:1186-1193.
34. Allais G., Gabellari I., Mana O., et al. Migraine and stroke: The role of oral contraceptives. Neurol Sci 2008, 29:S12-S14.
35. Allais G., Gabellari I., De Lorenzo C., et al. Oral contraceptives in migraine. Expert Rev Neurother 2009, 9:381-393.
36. Galvin J.A., Van Stavern G.P. Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 2004, 223:157-160.
37. Wall M. Idiopathic intracranial hypertension. Curr Neurol Neurosci Rep 2008, 8:87-93.
38. Ooi L.Y., Walker B.R., Bodkin A., et al. Idiopathic intracranial hypertension: Can studies of obesity provide the key to understanding pathogenesis?. Br J Neurosurg 2008, 22:187-194.
39. Sinclair A.J., Ball A.K., Burdon M.A., et al. Exploring the pathogenesis of IIH: An inflammatory perspective. J Neuroimmunol 2008, 201:212-220.
40. Donaldson J.O. Cerebrospinal fluid hypersecretion in pseudotumor cerebri. Trans Am Neurol Assoc 1979, 104:196-198.
41. Ball A.K., Clarke C.E. Idiopathic intracranial hypertension. Lancet Neurol 2006, 5:433.
42. Orefice G., Celentano L., Scaglione M., et al. Radioisotope cisternography in benign intracranial hypertension of young obese women. A seven-case study and pathogenic suggestions. Acta Neurol 1992, 14:39-50.
43. Janny P., Chazal J., Colnet G., et al. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981, 15:168-174.
44. King J.O., Mitchell P.J., Thomson K.R., et al. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002, 58:26-30.
45. Goodwin J. Recent developments in idiopathic intracranial hypertension. Semin Ophthalmol 2003, 18:181-189.
46. Jennum P., Borgesen S.E. Intracranial pressure and obstructive sleep apnea. Chest 1989, 95:279-283.
47. Sugerman H., Windsor A., Bessos M., et al. Intra-abdominal pressure sagittal abdominal diameter and obesity comorbidity. J Intern Med 1997, 241:71-79.
48. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919.
49. Hotamisgilil G.S., Shargill N.S., Speigelman B.M. Adipose expression of tumor necrosis factor -alpha: Direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
50. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
51. Ostlund R.E., Yang J.W., Klein S., Gingerich R., et al. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covaries. J Clin Endocrinol Metab 1996, 81:3909-3913.